5:24 AM
 | 
Jun 21, 2017
 |  BC Extra  |  Financial News

Sigilon debuts with $23.5M series A

Sigilon Therapeutics Inc. (Cambridge, Mass.) emerged from Flagship Pioneering's VentureLabs incubator with $23.5 million in series A funding...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >